Merck Manual

Please confirm that you are a health care professional

honeypot link

Metabolic and Bariatric Surgery

By

Shauna M. Levy

, MD, MS, Tulane University School of Medicine;


Michelle Nessen

, MD, Tulane University School of Medicine

Reviewed/Revised Nov 2023
View PATIENT EDUCATION
Topic Resources

Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae.

In the United States, about 260,000 bariatric operations are done in each year (1 Reference Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ). Development of safer, minimally invasive approaches has made this surgery more prevalent.

Reference

1. Clapp B, Ponce J, DeMaria, et al: American Society for Metabolic and Bariatric Surgery 2020 estimate of metabolic and bariatric procedures performed in the United State. Aurg Obes Relat Dis 18 (9):1134–1140, 2022. doi: 10.1016/j.soard.2022.06.284 Epub 2022 Jun 26.

Indications for Bariatric Surgery

In 2022, the American Society for Metabolic and Bariatric Surgery (ASMBS) and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) updated recommendations for metabolic and bariatric surgery to include patients with a BMI > 35 kg/m2 regardless of comorbidities and those with a BMI 30 to 34.5 kg/m2 with metabolic disorders. Comorbidities include the following:

The updated recommendations also specify that BMI thresholds should be adjusted in Asian populations and that patients with a BMI ≥ 27.5 kg/m2 should be offered surgery (1 Indications reference Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ).

Metabolic and bariatric surgery is offered as part of a weight-loss program that usually includes

  • Provider seminar classes

  • Psychological assessment of the patient

  • Consultation with a surgeon

  • Consultation with registered dietitians

  • Routine laboratory tests

  • Screening for obstructive sleep apnea (OSA)

  • Operative risk stratification

Contraindications include

Indications reference

  • 1. Eisenberg D, Shikora SA, Aarts E, et al: 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for metabolic and bariatric surgery. Surg Obes Relat Dis 18 (12):1345-1356, 2022. doi: 10.1016/j.soard.2022.08.013 Epub 2022 Oct 21.

Procedures for Bariatric Surgery

The most common metabolic and bariatric procedures performed in the United States include

Procedures such as the vertical banded gastroplasty or adjustable gastric banding are rarely used. Bariatric surgeons should be familiar with historical procedures because surgical complications can develop at any time—months to years—after surgery (1 Procedures references Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ).

Despite a growing percentage of the population with obesity, metabolic and bariatric surgery remains underused. Fewer than 1% of patients who qualify for surgery have the procedure. Telemedicine has allowed greater access to preoperative consultation; nonetheless, overall rates remain low (2 Procedures references Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ).

Usually, minimally invasive techniques—either laparoscopically or robotically—are used, resulting in less pain and a shorter healing time than after open surgery. Traditionally, bariatric surgery has been classified as restrictive and/or malabsorptive, referring to the presumptive mechanism of weight loss. However, other factors appear to contribute to weight loss; for example, both RYGB (traditionally classified as malabsorptive) and sleeve gastrectomy (traditionally classified as restrictive) result in metabolic or hormonal changes that favor satiety and weight loss and in other hormonal changes (eg, an increase in insulin release [incretin effect]) that appear to contribute to the rapid remission of diabetes Diabetes Mellitus (DM) Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... read more .

After RYGB (particularly) or sleeve gastrectomy, levels of gastrointestinal hormones, such as glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), are increased, possibly contributing to satiety, weight loss, and remission of diabetes. Increased insulin sensitivity is evident immediately postoperatively, before significant weight loss occurs, suggesting that neurohormonal factors are prominent in remission of diabetes. A change in gut microbiome may also contribute to changes in weight after RYGB. Metabolic and bariatric surgery reduces risk of mortality caused by cardiovascular disorders, diabetes, and cancer.

Sleeve gastrectomy

Sleeve gastrectomy is the most commonly used metabolic and bariatric surgical procedure in the United States. About 80% of the stomach is removed, creating a tubular stomach passage that resembles a banana. The resulting sleeve holds less food and thus reduces the number of calories consumed. Patients also experience less hunger, which correlates with decreased levels of ghrelin and other neurohormonal alterations. The procedures is technically simpler than bypass procedures and can be done as the first step toward a biliopancreatic diversion with duodenal switch (BPD-DS) or single anastomosis duodeno-ileal bypass with sleeve gastrectomy Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more (SADI-S). Sleeve gastrectomy does not alter the small intestine.

Roux-en-Y gastric bypass (RYGB) surgery

RYGB is considered a restrictive and malabsorptive procedure. A small part of the proximal stomach is detached from the rest, creating a stomach pouch of < 30 mL. Food bypasses part of the remaining stomach and proximal small intestine, where it is normally absorbed, reducing the amount of food and calories absorbed. The pouch is connected to the proximal jejunum; the opening between them is narrow, limiting the rate of gastric emptying. The segment of small intestine connected to the bypassed stomach is attached to the distal small intestine. This arrangement allows bile acids and pancreatic enzymes to mix with gastrointestinal contents, limiting malabsorption and nutritional deficiencies.

Short-term complications include anastomotic leak (more commonly at the gastrojejunal connection) and bleeding. Dumping syndrome can occur after eating high-fat and high-sugar foods; symptoms can include light-headedness, diaphoresis, nausea, abdominal pain, and diarrhea. Long-term risk of ulceration at the gastrojejunal anastomosis can occur in patients who take nonsteroidal anti-inflammatory drugs (NSAIDs) or smoke cigarettes after RYGB. Bowel obstruction can occur if internal hernia or intussusception develops.

Roux-en-Y Gastric Bypass Surgery

Roux-en-Y Gastric Bypass Surgery

Revisional procedures

An increasing number of patients are having revisional procedures to manage inadequate weight loss, weight regain, or other complications, such as development of GERD after sleeve gastrectomy.

For RYGB, revision may involve shortening the gastric pouch or the duodenal segment that is attached to the stomach. The purpose is reduce absorption of calories and nutrients.

Preoperative evaluation usually includes endoscopy and x-ray studies (eg, barium swallow).

Biliopancreatic diversion with a duodenal switch (BPD-DS)

BPD-DS accounts for < 5% of bariatric procedures done in the United States, but the annual number of procedures is increasing. It is usually reserved for patients with extreme morbid obesity (BMI > 50 kg/m2). BPD-DS can be done as one procedure or staged (first sleeve gastrectomy alone, then biliopancreatic diversion with duodenal switch after initial weight loss). About two-thirds to three-fourths of the upper small intestine is bypassed in the procedure.

After sleeve gastrectomy, the duodenum is divided just distal to the pylorus, and a segment of ileum is brought up and anastomosed to the proximal duodenum, creating an approximately 200-cm alimentary limb that bypasses much of the small intestine and the sphincter of Oddi (where bile acids and pancreatic enzymes enter). As a result, food absorption is decreased. The other cut end of the duodenum is tied off, and a second anastomosis is made between the remainder of the excluded loop and the ileum, creating a 100-cm channel for biliary and pancreatic enzymes to enter the distal small intestine and facilitate digestion.

BPD-DS is technically more difficult than sleeve gastrectomy or RYGB, but it is the most effective procedure for weight loss and resolution of type 2 diabetes. Complication rates are slightly higher than with other procedures, and malabsorption, steatorrhea, and nutritional deficiencies can occur. Patients must take nutritional supplements and be monitored for deficiencies for the rest of their life.

Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S)

Like BPD-DS, SADI-S includes sleeve gastrectomy and division at the first portion of the duodenum. It can be performed in one or two stages. The main difference is that SADI-S features a single loop anastomosis with a longer common channel for absorption. It is a slightly simpler and faster procedure and has less risk of nutritional deficiencies than BPD-DS. But it has a greater potential to worsen or lead to new-onset gastroesophageal Gastroesophageal Reflux Disease (GERD) Incompetence of the lower esophageal sphincter allows reflux of gastric contents into the esophagus, causing burning pain. Prolonged reflux may lead to esophagitis, stricture, and rarely metaplasia... read more Gastroesophageal Reflux Disease (GERD) reflux symptoms. Bile reflux can also occur because there is no roux limb.

Endoscopic procedures

Newer endoscopic procedures can help treat patients who are not candidates for surgery or who prefer a less invasive, nonsurgical approach.

An intragastric balloon may be used. An uninflated silicone balloon is passed into the stomach, then filled with saline. The balloon decreases gastric volume and promotes satiety. After 6 months, the balloon is removed. Patients lose weight initially, but long-term success is limited.

Endoscopic sleeve gastroplasty reduces the size of the stomach by suturing it from within. Because the sutures bring folds of the stomach together, it has been called the accordion procedure. Overall complication rates are low; the most common complications include nausea, gastrointestinal bleeding, perigastric leakage, and accumulation of fluid.

Sleeve gastroplasty has a lower reflux rate than endoscopic sleeve gastrectomy, and the procedure is potentially reversible. Five-year data suggest sustained weight loss; however, longer-term data are lacking (6 Procedures references Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ).

Adjustable gastric banding

Adjustable gastric banding is rarely performed in the United States. More often, patients who have had this procedure have the bands removed and undergo sleeve gastrectomy or RYGB.

For adjustable gastric banding, the band is placed around the upper part of the stomach to divide the stomach into a small upper pouch and a larger lower pouch. Typically, the band is adjusted 4 to 6 times by injecting saline into the band via a port that is placed subcutaneously. When saline is injected, the band expands, restricting the upper pouch of the stomach. As a result, the pouch can hold much less food, patients eat more slowly, and satiety occurs earlier. Saline can be removed from the band if a complication occurs or if the band is overly restrictive.

Weight loss with the band varies and is related to the frequency of follow-up; more frequent follow-ups result in greater weight loss. Early postoperative morbidity and mortality rates are lower than with other procedures. Long-term complications include gastroesophageal reflux, esophagitis, slipped bands, and erosion.

Removing the bands is sometimes technically challenging because scar tissue forms around the band.

Adjustable Gastric Banding

Adjustable Gastric Banding

Procedures references

Preoperative Evaluation for Metabolic and Bariatric Surgery

Preoperative evaluation consists of

  • Diagnosis and correction of comorbid conditions as much as possible

  • Assessment of readiness and ability to engage in lifestyle modification

  • Exclusion of contraindications to surgery

  • Review of the postoperative diet and assessment of the patient's ability to make dietary changes by a dietitian

  • Identification of any uncontrolled psychiatric disorder and any dependencies that would preclude surgery and identification and discussion of potential obstacles to adherence to lifestyle changes postoperatively by a psychologist or other qualified mental health care practitioner

Extensive preoperative evaluation is not routinely necessary, but preoperative testing may be necessary based on clinical findings, and measures to control certain conditions (eg, hypertension) or reduce risk may be taken.

Risks of Metabolic and Bariatric Surgery

Perioperative risks are lowest when metabolic and bariatric surgery is done in an accredited center.

Complications include

These complications can cause significant morbidity, prolong hospitalization, and increase costs. Tachycardia may be the only early sign of anastomotic leak.

Nutritional deficiencies (eg, protein-energy undernutrition Protein-Energy Undernutrition (PEU) Protein-energy undernutrition (PEU), previously called protein-energy malnutrition, is an energy deficit due to deficiency of all macronutrients, but primarily protein. It commonly includes... read more , vitamin B12 deficiency Vitamin B12 Deficiency Dietary vitamin B12 deficiency usually results from inadequate absorption, but deficiency can develop in vegans who do not take vitamin supplements. Deficiency causes megaloblastic anemia, damage... read more , iron deficiency Iron Deficiency Iron (Fe) is a component of hemoglobin, myoglobin, and many enzymes in the body. Heme iron is contained mainly in animal products. It is absorbed much better than nonheme iron (eg, in plants... read more ) may result from inadequate intake, inadequate supplementation, or malabsorption. Malodorous flatulence, diarrhea, or both may develop, particularly after malabsorptive procedures. Calcium and vitamin D absorption may be impaired, causing deficiencies and sometimes hypocalcemia Hypercalcemia Hypercalcemia is a total serum calcium concentration > 10.4 mg/dL (> 2.60 mmol/L) or ionized serum calcium > 5.2 mg/dL (> 1.30 mmol/L). Principal causes include hyperparathyroidism... read more and secondary hyperparathyroidism. With prolonged vomiting, thiamin deficiency Thiamin Deficiency Thiamin deficiency (causing beriberi) is most common among people subsisting on white rice or highly refined carbohydrates in countries with high rates of food insecurity and among people with... read more may occur.

Incidence of psychologic disorders such as depression Depressive Disorders Depressive disorders are characterized by sadness severe enough or persistent enough to interfere with function and often by decreased interest or pleasure in activities. Exact cause is unknown... read more is increased in patients having metabolic and bariatric surgery. A 2016 meta-analysis confirmed this increase in preoperative depression and reported a postoperative decrease in the prevalence and severity of depression (1 Risks references Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ). In a large review of retrospective and prospective studies, self-harm and suicide were higher in patients after metabolic and bariatric surgery than in control subjects; various presurgical and postsurgical factors may be involved (2 Risks references Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ). Incidence of alcohol use disorder Alcohol Use Disorder and Rehabilitation Alcohol use disorder involves a pattern of alcohol use that typically includes craving and manifestations of tolerance and/or withdrawal along with adverse psychosocial consequences. Alcoholism... read more also appears to be increased after bariatric surgery (3 Risks references Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ).

Eating habits may be disordered. Adjusting to new eating habits can be difficult.

Risks references

  • 1. Dawes AJ, Maggard-Gibbons M, Maher AR, et al: Mental health conditions among patients seeking and undergoing bariatric surgery: A meta-analysis. JAMA 315 (2):150–163, 2016. doi: 10.1001/jama.2015.18118

  • 2. Castaneda D, Popov VB, Wander P, et al:Risk of suicide and self-harm is increased after bariatric surgery—A systematic review and meta-analysis. Obes Surg 29 (1):322–333, 2019. doi: 10.1007/s11695-018-3493-4

  • 3. Heinberg LJ, Ashton K, Coughlin J: Alcohol and bariatric surgery: review and suggested recommendations for assessment and management. Surg Obes Relat Dis 8 (3):357-363, 2012. doi: 10.1016/j.soard.2012.01.016

Prognosis for Metabolic and Bariatric Surgery

In hospitals accredited by the American Society of Bariatric Surgery as centers of excellence (COE), in-hospital mortality was 0.08% (1 Prognosis references Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ). However, some data indicate that lower rates of serious complications are predicted more accurately by the number of procedures done in the hospital and by the surgeon than by COE status. Risk of death associated with bariatric surgery is about 0.1%; overall risk of serious complications is about 4%. For most patients, the risk of obesity and its complications outweigh the immediate risk of surgery (2 Prognosis references Metabolic and bariatric surgery is the surgical alteration of the stomach, intestine, or both to cause weight loss in patients with obesity-related metabolic disorders and their sequellae. In... read more ).

Average excess weight loss depends on the procedure.

For sleeve gastrectomy, loss of excess weight is

  • 33 to 58% at 2 years

  • 58 to 72% at 3 to 6 years

For Roux-en-Y gastric bypass, loss of excess weight is

  • 50 to 65% after 2 years

Weight loss after RYGB is maintained for up to 10 years.

For BPD-DS and SADI-S, patients lose

  • 75 to 90% of excess body weight

Prognosis references

Follow-up after Bariatric Surgery

Regular long-term follow-up after metabolic and bariatric surgery helps ensure adequate weight loss and prevent complications. After Roux-en-Y gastric bypass or sleeve gastrectomy, patients should be monitored every 4 to 12 weeks during the period of rapid weight loss (usually about the first 6 months after surgery), then every 6 to 12 months thereafter.

Weight and blood pressure are checked, and eating habits are reviewed. Blood tests (usually complete blood count; electrolyte, glucose, blood urea nitrogen, creatinine, albumin, and protein levels; and liver tests) are done at regular intervals. Glycosylated Hb (HbA1c) and fasting lipid levels should be monitored if they were abnormal before surgery. Depending on the type of procedure, vitamin and mineral levels, including calcium, vitamin D, vitamin B12, folate, iron, and thiamin (vitamin B1), may need to be monitored. Because secondary hyperparathyroidism is a risk, parathyroid hormone levels should also be monitored. Bone density should be measured after sleeve gastrectomy or Roux-en-Y gastric bypass.

Clinicians should check for any changes in response to antihypertensives, insulin, oral hypoglycemics, or lipid-lowering medications during the period of rapid weight loss after surgery.

To minimize risk of hypoglycemia Hypoglycemia Hypoglycemia, or low plasma glucose level can result in sympathetic nervous system stimulation and central nervous system dysfunction. In patients with diabetes who take insulin or antihyperglycemic... read more (due to increased insulin sensitivity after bariatric surgery) in patients with diabetes, clinicians should adjust the dose of insulin and decrease the dose of oral hypoglycemics (particularly sulfonylureas) or stop them after Roux-en-Y gastric bypass or sleeve gastrectomy.

Key Points

  • Consider weight loss surgery if patients have a BMI of > 35 kg/m2 or a BMI of > 30 kg/m2 plus obesity-related comorbidities (eg, diabetes, hypertension, obstructive sleep apnea, high-risk lipid profile).

  • Contraindications to metabolic and bariatric surgery include an uncontrolled psychiatric disorder (eg, major depression), substance or alcohol use disorder, cancer that is not in remission, or another life-threatening disorder and inability to comply with nutritional requirements (including life-long vitamin replacement when indicated).

  • Sleeve gastrectomy is currently the most commonly used metabolic and bariatric surgical procedure in the United States.

  • Monitor patients regularly after surgery for maintenance of weight loss, resolution of weight-related comorbidities, and complications of surgery (eg, nutritional deficiencies, metabolic bone disease, gout, cholelithiasis, nephrolithiasis, depression, alcohol use disorder).

Drugs Mentioned In This Article

Drug Name Select Trade
GIAPREZA
Calcidol, Calciferol, D3 Vitamin, DECARA, Deltalin, Dialyvite Vitamin D, Dialyvite Vitamin D3, Drisdol, D-Vita, Enfamil D-Vi-Sol, Ergo D, Fiber with Vitamin D3 Gummies Gluten-Free, Happy Sunshine Vitamin D3, MAXIMUM D3, PureMark Naturals Vitamin D, Replesta, Replesta Children's, Super Happy SUNSHINE Vitamin D3, Thera-D 2000, Thera-D 4000, Thera-D Rapid Repletion, THERA-D SPORT, UpSpring Baby Vitamin D, UpSpring Baby Vitamin D3, YumVs, YumVs Kids ZERO, YumVs ZERO
Aluvea , BP-50% Urea , BP-K50, Carmol, CEM-Urea, Cerovel, DermacinRx Urea, Epimide-50, Gord Urea, Gordons Urea, Hydro 35 , Hydro 40, Kerafoam, Kerafoam 42, Keralac, Keralac Nailstik, Keratol, Keratol Plus, Kerol, Kerol AD, Kerol ZX, Latrix, Mectalyte, Nutraplus, RE Urea 40, RE Urea 50 , Rea Lo, Remeven, RE-U40, RYNODERM , U40, U-Kera, Ultra Mide 25, Ultralytic-2, Umecta, Umecta Nail Film, URALISS, Uramaxin , Uramaxin GT, Urea, Ureacin-10, Ureacin-20, Urealac , Ureaphil, Uredeb, URE-K , Uremez-40, Ure-Na, Uresol, Utopic, Vanamide, Xurea, X-VIATE
Albuked , Albumarc, Albuminar, Albuminex, AlbuRx , Albutein, Buminate, Flexbumin, Kedbumin, Macrotec, Plasbumin, Plasbumin-20
NATPARA
Afrezza, Exubera
View PATIENT EDUCATION
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz! 
iOS ANDROID
iOS ANDROID
iOS ANDROID
TOP